欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
  • 文章
  • 报告
  • 图书
  • 公募
  • 私募
  • 资讯
搜 索
上传文档
您的当前位置:首页 > 研究报告 > 外盘报告 > 预览报告
Superior PFS vs ibrutinib in r/r CLL further supports the best-in-class potential of zanubrutinib
报告类型:美股公司研究 页数:5 文件大小:1.0M 上传时间:2023-10-31
机构:招银国际 作者:Jill Wu Andy Wang 225阅读 0收藏 0下载
下载PDF
下载全文所需积分:1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
{{Creator}} 回复 {{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
mtachn.com
© 2013 mtachn,. All Rights Reserved.
苏ICP备48665885号-3
微信公众号
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=4377408","PageTitle":"Superior PFS vs ibrutinib in r/r CLL further supports the best-in-class potential of zanubrutinib-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":27,"Face":"/_files/face/0/2ns4yx2k.jpg","UName":"图门涵衍","UpArts":0,"UpRpts":23120,"UpLbies":23},"Rid":4377408,"IsPdf":false,"IsExist":false,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20221014-招银国际-SuperiorPFSvsibrutinibinrrCLLfurthersupportsthebest-in-classpotentialof","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}} 湘财证券晨会纪要-晨会报告 - 研究报告 | 金融市场技术研究院
欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
  • 文章
  • 报告
  • 图书
  • 公募
  • 私募
  • 资讯
搜 索
上传文档
您的当前位置:首页 > 研究报告 > 晨会报告 > 预览报告
湘财证券晨会纪要
报告类型:晨会纪要 页数:0 文件大小: 上传时间:2024-05-14
机构:湘财证券 作者:陈国俊 50阅读 0收藏 0下载
下载PDF
下载全文所需积分:1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
{{Creator}} 回复 {{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
mtachn.com
© 2013 mtachn,. All Rights Reserved.
苏ICP备48665885号-3
微信公众号
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5338319","PageTitle":"湘财证券晨会纪要-晨会报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":8,"Face":"/_files/face/0/02lshcq4.jpg","UName":"HelloItsME","UpArts":0,"UpRpts":23085,"UpLbies":30},"Rid":5338319,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/晨会报告/20111103-湘财证券-湘财证券晨会纪要.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}